<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-early-stage-focused-fund-invests-in-seed-to-series-a-rounds-in-digital-health-and-healthtech-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-30T16:23:12+00:00</news:publication_date><news:title>Hot Investor Mandate: Early-Stage Focused Fund Invests in Seed to Series A Rounds in Digital Health and Healthtech Companies</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/06/30/hot-investor-mandate-private-investment-firm-with-asset-centric-approach-invests-in-promising-early-stage-therapeutics-assets/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-30T16:22:40+00:00</news:publication_date><news:title>Hot Investor Mandate: Private Investment Firm with Asset-Centric Approach Invests in Promising Early-Stage Therapeutics Assets</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url></urlset>
